IndraLab

Statements



reach
"The MAPK-JNK pathway inhibitor SP600125 clearly blocked the antiviral effect of TAK1 (XREF_FIG, lane 10), indicating the essential role of this pathway in controlling of HBV replication."

reach
"Furthermore, the JNK pathway was apparently responsible for the suppression of HBV replication, as the JNK inhibitor, SP600125, and JNK3 siRNA attenuated the antiviral effects of TAK1."